Please use this identifier to cite or link to this item:
|Title:||The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton.||Austin Authors:||Roberts, Emma;Cossigny, Davina A F;Quan, Gerald M Y||Affiliation:||Spinal Biology Research Laboratory, University of Melbourne, Department of Surgery, Austin Health, P.O. Box 5555, Heidelberg, VIC 3084, Australia ; Department of Spinal Surgery, Austin Health, P.O. Box 5555, Heidelberg, VIC 3084, Australia
Spinal Biology Research Laboratory, University of Melbourne, Department of Surgery, Austin Health, P.O. Box 5555, Heidelberg, VIC 3084, Australia
|Issue Date:||12-Dec-2013||Publication information:||Prostate Cancer 2013; 2013(): 418340||Abstract:||Despite the clinical implication and high incidence of bone and spinal metastases, the molecular mechanisms behind prostate cancer metastasis to bone and spine are not well understood. In this review the molecular mechanisms that may contribute to the highly metastatic phenotype of prostate cancer are discussed. Proangiogenic factors such as vascular endothelial growth factor (VEGF) have been shown to not only aid in the metastatic capabilities of prostate cancer but also encourage the colonization and growth of prostate tumour cells in the skeleton. The importance of VEGF in the complex process of prostate cancer dissemination to the skeleton is discussed, including its role in the development of the bone premetastatic niche, metastatic tumour cell recognition of bone, and bone remodeling. The expression of VEGF has also been shown to be upregulated in prostate cancer and is associated with clinical stage, Gleason score, tumour stage, progression, metastasis, and survival. Due to the multifaceted effect VEGF has on tumour angiogenesis, tumour cell proliferation, and bone destruction, therapies targeting the VEGF pathways have shown promising clinical application and are being investigated in clinical trials.||Gov't Doc #:||24396604||URI:||http://ahro.austin.org.au/austinjspui/handle/1/12024||DOI:||10.1155/2013/418340||URL:||https://pubmed.ncbi.nlm.nih.gov/24396604||Type:||Journal Article|
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 6, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.